Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-08 4:31 pm Purchase | 2022-03-31 | 13G | Cytokinetics, Incorporated CYTK | The Vanguard Group | 8,741,124 10.300% | 1,751,405 (+25.06%) | Filing History |
| 2022-02-14 09:42 am Sale | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,327,112 2.770% | -712,144 (-23.43%) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | The Vanguard Group | 6,989,719 8.330% | 2,167,729 (+44.96%) | Filing History |
| 2022-02-09 12:49 pm Sale | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 3,985,227 4.750% | -655,696 (-14.13%) | Filing History |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 12,589,835 14.999% | 4,101,153 (+48.31%) | Filing History |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 12,950,964 15.400% | 0 (Unchanged) | Filing History |
| 2022-01-25 6:45 pm Purchase | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 12,950,964 15.400% | 1,339,885 (+11.54%) | Filing History |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 8,488,682 11.832% | 5,864,957 (+223.54%) | Filing History |
| 2021-02-19 5:02 pm Sale | 2021-02-18 | 13G | Cytokinetics, Incorporated CYTK | Eastern Capital LTD | 3,062,748 4.300% | -544,781 (-15.10%) | Filing History |
| 2021-02-16 3:16 pm Sale | 2020-12-31 | 13G | Cytokinetics, Incorporated CYTK | Point72 Asset Management, L.P. | 1,176,653 1.700% | -1,855,196 (-61.19%) | Filing History |
| 2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | Cytokinetics, Incorporated CYTK | The Vanguard Group | 4,821,990 6.810% | 276,000 (+6.07%) | Filing History |
| 2021-02-08 10:07 am Purchase | 2020-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 4,640,923 6.560% | 2,724,961 (+142.22%) | Filing History |
| 2021-01-25 4:50 pm Purchase | 2020-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 11,611,079 16.400% | 2,050,477 (+21.45%) | Filing History |
| 2021-01-13 4:56 pm Sale | 2021-01-11 | 13G | Cytokinetics, Incorporated CYTK | BIOTECHNOLOGY VALUE FUND LP | 2,728,035 3.900% | -4,629,984 (-62.92%) | Filing History |
| 2020-11-16 5:29 pm Purchase | 2020-11-12 | 13G | Cytokinetics, Incorporated CYTK | BIOTECHNOLOGY VALUE FUND LP | 7,358,019 10.400% | 3,419,739 (+86.83%) | Filing History |